Camrelizumab plus rivoceranib versus sorafenib as first-line therapy for unresectable hepatocellular carcinoma (CARES-310): a randomised, open-label, international phase 3 study von Qin, Shukui, Chan, Stephen L, Bai, Yuxian, Chen, Zhendong, Jia, Weidong, Jin, Yongdong, Guo, Yabing, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Chen, Yajin, Zeng, Yong, Sultanbaev, Alexander, Pazgan-Simon, Monika, Melisi, Davide, Ponomarenko, Dmitriy, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Wang, Linna, Cheng, Ann-Lii, Vogel, Arndt, Qin, Shukui, Chan, Stephen L, Vogel, Arndt, Gu, Shanzhi, Bai, Yuxian, Ren, Zhenggang, Lin, Xiaoyan, Chen, Zhendong, Hu, Xiaohua, Meng, Zhiqiang, Liang, Jun, Cheng, Ying, Xiong, Jianping, Ren, Hong, Yang, Fang, Zeng, Yong, Sultanbaev, Alexander, Pisetska, Margaryta, Melisi, Davide, Ponomarenko, Dmitriy, Osypchuk, Yurii, Sinielnikov, Ivan, Yang, Tsai-Sheng, Liang, Xiao, Chen, Chunxia, Zhang, Mingxiang, Xu, Li, Li, Da, Ying, Jierer, Zhang, Jingdong, Zhang, Tao, He, Yifu, Jiang, Da, Xing, Baocai, Zhang, Baihong, Wang, Dong, Zhai, Xiaofeng, Liang, Houjie, Cybulska-Stopa, Bozena, Dvorkin, Mikhail, Stroyakovskiy, Daniil, Yen, Chia-Jui, Su, Wei-Wen, Chen, Yen-Hao, Bondarenko, Igor, Fang, Weijia, Gomez-Martin, Carlos, Ryu, Min-Hee, Kim, Han-Sang, Kim, Jee-Hyun, Orlova, Rashida, Fadeeva, Natalia, Makarova, Yulia, Hung, Chao-Hung, Neffa, Maryna, Vynnychenko, Oleksandr, Burgoyne, Adam, Hao, Chunyi, Mohr, Raphael U, Diaz-Beveridge, Roberto, Feliu-Batlle, Jaime, Antonuzzo, Lorenzo, Scartozzi, Mario, Ahn, Mi Sun, Oh, Sung-Yong, Orlov, Sergey, Oksuzoglu, Berna, Rau, Kun-Ming, Krechkovskyi, Oleksandr, Yareshko, Vladimir, Xiong, Henry, Lee, Fa-Chyi, Jiang, Yixing, Verset, Gontran

Volltext

Better survival after stereotactic body radiation therapy following transarterial chemoembolization in nonresectable hepatocellular carcinoma: A propensity score matched analysis von Wong, Tiffany CL, Chiang, Chi-Leung, Lee, Ann-Shing, Lee, Victor HF, Yeung, Cynthia SY, Ho, Connie HM, Cheung, Tan-To, Ng, Kelvin KC, Chok, Siu-Ho, Chan, Albert CY, Dai, Wing-Chiu, Wong, Frank CS, Luk, Mai-Yee, Leung, To-Wai, Lo, Chung-Mau

Volltext

Consensus on Stereotactic Body Radiation Therapy for Small-Sized Hepatocellular Carcinoma at the 7th Asia-Pacific Primary Liver Cancer Expert Meeting von Zeng, Zhao-Chong, Seong, Jinsil, Yoon, Sang Min, Cheng, Jason Chia-Hsien, Lam, Ka-On, Lee, Ann-Shing, Law, Ada, Zhang, Jian-Ying, Hu, Yong

Volltext

Combined Stereotactic Body Radiotherapy and Immunotherapy Versus Transarterial Chemoembolization in Locally Advanced Hepatocellular Carcinoma: A Propensity Score Matching Analysis von Chiang, Chi-Leung, Chiu, Keith Wan-Hang, Lee, Francis Ann-Shing, Kong, Feng-Ming Spring, Chan, Albert Chi-Yan

Volltext

Hong Kong Consensus Statements for the Management of Unresectable Hepatocellular Carcinoma von Cheung, Tom Tan-To, Kwok, Philip Chong-Hei, Chan, Stephen, Cheung, Chin-Cheung, Lee, Ann-Shing, Lee, Victor, Cheng, Hoi-Ching, Chia, Nam-Hung, Chong, Charing C.N., Lai, Tak-Wing, Law, Ada L.Y., Luk, Mai-Yee, Tong, Chi Chung, Yau, Thomas C.C.

Volltext

Hong Kong Consensus Recommendations on the Management of Hepatocellular Carcinoma von Poon, Ronnie Tung-Ping, Cheung, Tom Tan-To, Kwok, Philip Chong-Hei, Lee, Ann-Shing, Li, Tat-Wing, Loke, Kwok-Loon, Chan, Stephen Lam, Cheung, Moon-Tong, Lai, Tak-Wing, Cheung, Chin-Cheung, Cheung, Foon-Yiu, Loo, Ching-Kong, But, Yiu-Kuen, Hsu, Shing-Jih, Yu, Simon Chun-Ho, Yau, Thomas

Volltext

Neoadjuvant short-course radiotherapy or chemoradiation plus consolidative chemotherapy followed by radical operation for locally advanced rectal cancer von Lee, Shing Fung, Yip, Pui Lam, Wo, Barry, Wong, Natalie Sean-Man, Vellayappan, Balamurugan A, Mamon, Harvey J, Lee, Francis Ann Shing

Volltext

Effectiveness and safety of capecitabine, irinotecan and panitumumab in advanced colorectal cancer von Yip, Pui Lam, Fung, Wai Him Brian, Lee, Francis Ann Shing, Lee, Chak Fei, Wong, Natalie Sean Man, Lee, Shing Fung

Volltext

Splenic irradiation contributes to grade ≥ 3 lymphopenia after adjuvant chemoradiation for stomach cancer von Lee, Shing Fung, Yip, Pui Lam, Wong, Aray, Ng, Francesca, Koh, Vicky, Wong, Lea Choung, Luk, Hollis, Ng, Chuk Kwan, Lee, Francis Ann Shing, Mamon, Harvey J.

Volltext

Nasopharyngeal intracavitary brachytherapy : The controversy of T2b disease von LEUNG, To-Wai, TUNG, Stewart Y, WONG, Victy Y. W, SZE, Wing-Kin, LUI, Collin M. M, WONG, Frank C. S, LEE, Ann-Shing, O, Sai-Ki

Volltext

Survival Outcome Analysis of Stereotactic Body Radiotherapy and Immunotherapy (SBRT-IO) versus SBRT-Alone in Unresectable Hepatocellular Carcinoma von Chiang, Chi Leung, Lee, Francis Ann Shing, Chan, Kenneth Sik Kwan, Lee, Venus Wan Yan, Chiu, Keith Wan Hang, Ho, Ryan Lok Man, Fong, John Ka Shun, Wong, Natalie Sean Man, Yip, Winnie Wing Ling, Yeung, Cynthia Sin Yu, Lau, Vince Wing Hang, Man, Kwan, Kong, Feng-Ming Spring, Chan, Albert Chi Yan

Volltext

Outcome of neoadjuvant chemoradiation in MRI staged locally advanced rectal cancer: Retrospective analysis of 123 Chinese patients von Lee, Shing Fung, Chiang, Chi Leung, Lee, Francis Ann Shing, Wong, Yiu Wah, Poon, Chi Ming, Wong, Frank Chi Sing, Tung, Stewart Yuk

Volltext

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma von Sangro, B., Chan, S.L., Kelley, R.K., Yarchoan, M., Furuse, J., Kang, Y.K., Galle, P.R., Heurgué, A., Van Dao, T., Breder, V., Reig, M., Negro, A., Abou-Alfa, G.K., Branco, Ricardo, Faccio, Adilson, Skare, Nils, Dutra, Jamille, Viola, Luciana, Vianna, Karina, Sette, Claudia, Faulhaber, Amanda, Tam, Vincent C., Mulder, Karen, Zbuk, Kevin, Beaudoin, Annie, Assenat, Eric, Tougeron, David, Peron, Jean-Marie, Cattan, Stephane, Phelip, Jean-Marc, Michel, Pierre, Vogel, Arndt, Berg, Thomas, Wedemeyer, Hans Heinrich, Worns, Marcus-Alexander, Tai, Yin Ping, Lee, Ann Shing, N, Lokesh K., Ashok, Kattimani Kiran, Mittal, Sushant, Goyal, Hari, Srinivasan, Sankar, Mohan, Mallavarapu, Asarawala, Nirav, Gasbarrini, Antonio, Daniele, Bruno, Roila, Fausto, Osaki, Yukio, Motomura, Kenta, Tsuji, Kunihiko, Takei, Yoshiyuki, Aramaki, Takeshi, Kioka, Kiyohide, Koga, Hironori, Sasaki, Yutaka, Tada, Toshifumi, Nadano, Seijin, Vasilyev, Alexander, Kutukova, Svetlana, Ponomarev, Roman, Petrov, Yuryi, Erygin, Dmitriy, Kang, Yoon-Koo, Lim, Ho Yeong, Kim, Jee Hyun, Kim, Tae-You, Choi, Hye Jin, Sangro, Bruno, Martin, Carlos Gómez, López, Carlos, Cheng, Ann-Lii, Feng, Yin-Hsun, Hou, Ming-Mo, Wang Tsang-En Wang, Jing-Houng, Yen, Chia-Jui, Sunpaweravong, Patrapim, Charoentum, Chaiyut, Tanasanvimon, Suebpong, Sirachainan, Ekaphop, Ungtrakul, Teerapat, Ostapenko, Yurii, Skoryi, Denys, Bondarenko, Igor, Shparyk, Yaroslav, Trukhin, Dmytro, Hotko, Yevhen, Kryzhanivska, Anna, Mody, Kabir, Al-Rajabi, Raed, Crysler, Oxana, He, Aiwu Ruth, Reeves, James, Mahipal, Amit, Dasgupta, Anirudha, Thota, Ramya, Crocenzi, Todd, Denlinger, Crystal, Sharma, Nisha, Dao, Tu V., Tuyet Phuong, Le Thi

Volltext

Nasopharyngeal intracavitary brachytherapy von Leung, To‐Wai, Tung, Stewart Y., Wong, Victy Y. W., Sze, Wing‐Kin, Lui, Collin M. M., Wong, Frank C. S., Lee, Ann‐Shing, O, Sai‐Ki

Volltext

Sequential trans-arterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy (START-FIT) for locally advanced hepatocellular carcinoma: A single-arm, ph... von Chiang, Chi Leung, Chiu, Wan Hang Keith, Lau, Wing Hang Vince, Chan, Sik-Kwan, Lee, Ann Shing, Kong, Feng-Ming Spring, Chan, Albert

Volltext

Preliminary results of sequential transarterial chemoembolization and stereotactic body radiotherapy followed by immunotherapy using single tremelimumab regular interval durvalumab... von Chiang, Chi Leung, Chang, Stephen Lam, Chan, Sik-Kwan, Lee, Ann Shing, Chiu, Keith Wan Hang, Yeung, Vanessa Ting Yan, Wong, Natalie Sean Man, Lee, Venus Wan Yan, Lau, Vince Wing Hang, Man, Nancy Kwan, Kong, Feng-Ming Spring, Chan, Albert Chi Yan

Volltext

MO1-5-5 [Encore]Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) vs sorafenib in patients with advanced HCC von Yau, Thomas, Kwok, Gin Wai, Tang, Vikki, Leung, Roland, Lee, Ann-Shing, Law, Ada, Chiu, Joanne, Li, Bryan, Cheung, Tan-To

Volltext

Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) vs sorafenib in patients with advanced HCC von Yau, Thomas, Kwok, Gin Wai, Tang, Vikki, Leung, Roland, Lee, Ann-Shing, Law, Ada, Chiu, Joanne, Li, Bryan, Cheung, Tan-To

Volltext

Randomized phase II trial of sorafenib, capecitabine, and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma von Kwok, Gin Wai, Tang, Vikki, Leung, Roland Ching-Yu, Lee, Ann-Shing, Law, Ada, Chiu, Joanne Wing Yan, Li, Bryan, Cheung, Tan To, Yau, Thomas

Volltext

Randomized phase II trial of sorafenib, capecitabine and oxaliplatin (SECOX) versus single agent sorafenib in patients with advanced hepatocellular carcinoma von Yau, Thomas Cheung, Tang, Vikki, Leung, Roland Ching-Yu, Kwok, Gin Wai, Lee, Ann-Shing, Law, Ada, Chiu, Joanne, Li, Bryan, Cheung, Tan To

Volltext